Every year in the EU, it is estimated that 4.1 million people are affected by HAIs. This results in 37,000 deaths and adds estimated costs of over €6 billion, according to the European Centre for Disease Prevention and Control (ECDC).
In vitro diagnostics (IVDs) can accurately diagnose patients with drug-resistant infections so that they can be appropriately managed. Healthcare institutions can also use this diagnostic information to reduce the risk of other patients being infected.
For example, staff can follow specific infection-control protocols when caring for the infectious patient and take steps to limit contact between patients. Protective clothing and adequate sterilization of surgical devices are also essential to good hygiene and patient safety.